Pacific Biosciences of California, Inc.
PACB· Nasdaq
PACBPacific Biosciences of California, Inc.
Released Aug 3, 2020, after the close
10-Q filed Aug 6, 2020, 37 days after period end · 0001299130-20-000122
| Metric | Q2 2020 | Q2 2019 | Q2 2018 | Q2 2017 |
|---|---|---|---|---|
| Revenue | $19.08M | $24.62M | $21.58M | $20.07M |
| Net Income | -$23.09M | -$24.60M | -$22.54M | -$25.54M |
| EPS Diluted |
Pacific Biosciences of California, Inc. · CIK 1299130 · Engraved from SEC EDGAR
| -$0.15 |
| -$0.16 |
| -$0.17 |
| -$0.26 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
